Elizabeth E. Morgan
Vice President, Clinical Operations

Ms. Morgan has over 20 years of experience in the biotechnology industry, including clinical operations, regulatory affairs and quality assurance responsibilities. Ms. Morgan has been involved in the successful filing of over 25 Investigational New Drug applications and 2 NDAs for new chemical entities/biologics with the US Food and Drug Administration. She has conducted numerous Phase I-III clinical trials in areas of cancer, HIV, autoimmune diseases, infectious diseases, cardiovascular, allergy and asthma and skin replacement. Ms. Morgan was most recently Vice President, Clinical Operations at Nereus Pharmaceuticals. Prior to that, Ms. Morgan held executive positions at Hollis Eden Pharmaceuticals and The Immune Response Corporation as well as positions at Advanced Tissue Sciences and Dura Pharmaceuticals. Ms. Morgan received her B.S. from San Diego State University.